Literature DB >> 24215537

The impact of smoking status on 9.3 years incidence of cardiovascular and all-cause mortality among Iranian men.

Solmaz Ehteshami-Afshar1, Amirabbas Momenan, Farhad Hajshekholeslami, Fereidoun Azizi, Farzad Hadaegh.   

Abstract

AIM: To examine the association of different smoking groups with cardiovascular disease (CVD), coronary heart diseases (CHD) and CVD attributed death and death due to all causes in a male Tehranian population.
METHODS: From a population-based study 3059 male individuals, aged ≥30 years, free of CVD at baseline were evaluated for a median of 9.3 years. The adjusted hazard ratios (HRs) for incident CVD/CHD, total and CVD mortality regarding their smoking status were calculated using Cox proportional regression analysis, considering never smoking as reference.
RESULTS: A total of 158 deaths, in which 78 were CVD attributable, occurred. Considering CVD and CHD events, this study identified 299 and 257 events, respectively. Being a past smoker significantly increased the risk of CVD events (HR = 2.42, CI = 1.28-0.56), however, it has no effect on CHD events, total and CVD mortality. Being a current smoker (more than 10 cigarettes a day) dramatically increased the risk of CVD/CHD events and total/CVD mortality. However, smoking less than 10 cigarettes per day only increased the risk of CVD (HR = 2.12, CI = 1.14-3.95) and its mortality (HR = 4.57, CI = 1.32-15.79).
CONCLUSION: The findings indicate that smoking increases the risk of incident CVD/CHD, total and CVD mortality, particularly CVD mortality. These outcomes were attributable to the daily amount of cigarettes smoked. Past smokers still had higher risk for CVD events, which cessation may not reduce.

Entities:  

Mesh:

Year:  2013        PMID: 24215537     DOI: 10.3109/03014460.2013.853834

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  6 in total

1.  Smoking intensity (pack/day) is a better measure than pack-years or smoking status for modeling cardiovascular disease outcomes.

Authors:  Robin Nance; Joseph Delaney; John W McEvoy; Michael J Blaha; Gregory L Burke; Ana Navas-Acien; Joel D Kaufman; Elizabeth C Oelsner; Robyn L McClelland
Journal:  J Clin Epidemiol       Date:  2016-10-18       Impact factor: 6.437

2.  Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study.

Authors:  Younes Jahangiri-Noudeh; Samaneh Akbarpour; Mojtaba Lotfaliany; Neda Zafari; Davood Khalili; Maryam Tohidi; Mohammad Ali Mansournia; Fereidoun Azizi; Farzad Hadaegh
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

3.  Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports.

Authors:  Allan Hackshaw; Joan K Morris; Sadie Boniface; Jin-Ling Tang; Dušan Milenković
Journal:  BMJ       Date:  2018-01-24

Review 4.  Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Donna Parizadeh; Amir Abbas Momenan; Atieh Amouzegar; Fereidoun Azizi; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-31

5.  The Effects of Smoking on Metabolic Syndrome and Its Components Using Causal Methods in the Iranian Population.

Authors:  Farzad Khodamoradi; Maryam Nazemipour; Nasrin Mansournia; Kamran Yazdani; Davood Khalili; Mohammad Ali Mansournia
Journal:  Int J Prev Med       Date:  2021-09-29

6.  Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study.

Authors:  Farzad Hadaegh; Arash Derakhshan; Amirhossein Mozaffary; Mitra Hasheminia; Davood Khalili; Fereidoun Azizi
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.